Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

Conditions:   Stage II Bladder Cancer AJCC v8;   Stage IIIA Bladder Cancer AJCC v8 Interventions:   Drug: Cisplatin;   Drug: Doxorubicin;   Drug: Methotrexate;   Biological: Pegfilgrastim;   Biological: Pembrolizumab;   Procedure: Radical Cystectomy;   Drug: Vinblastine;   Drug: Vinblastine Sulfate Sponsors:   University of Washington;   National Cancer Institute (NCI);   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials